Ligand Pharmaceuticals Inc banner

Ligand Pharmaceuticals Inc
NASDAQ:LGND

Watchlist Manager
Ligand Pharmaceuticals Inc Logo
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Watchlist
Price: 185.65 USD -2.26% Market Closed
Market Cap: $3.7B

Wall Street
Price Targets

LGND Price Targets Summary
Ligand Pharmaceuticals Inc

Wall Street analysts forecast LGND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LGND is 248.31 USD with a low forecast of 222.2 USD and a high forecast of 288.75 USD.

Lowest
Price Target
222.2 USD
20% Upside
Average
Price Target
248.31 USD
34% Upside
Highest
Price Target
288.75 USD
56% Upside
Ligand Pharmaceuticals Inc Competitors:
Price Targets
TENB
Tenable Holdings Inc
64% Upside
INBK
First Internet Bancorp
32% Upside

Revenue
Forecast

14% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
14% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 13 years the compound annual growth rate for Ligand Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 4 years is 23%.

Operating Income
Forecast

21% / Year
Past Growth
65% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
21% / Year
Past Growth
65% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

For the last 13 years the compound annual growth rate for Ligand Pharmaceuticals Inc's operating income is 21%. The projected CAGR for the next 4 years is 65%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LGND's stock price target?
Price Target
248.31 USD

According to Wall Street analysts, the average 1-year price target for LGND is 248.31 USD with a low forecast of 222.2 USD and a high forecast of 288.75 USD.

What is Ligand Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
23%

For the last 13 years the compound annual growth rate for Ligand Pharmaceuticals Inc's revenue is 14%. The projected CAGR for the next 4 years is 23%.

What is Ligand Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
65%

For the last 13 years the compound annual growth rate for Ligand Pharmaceuticals Inc's operating income is 21%. The projected CAGR for the next 4 years is 65%.

Back to Top